• +886-3-5797779 Fax.105

progress_bar test

Program Target Lead optimization Pre-clinical IND enabling Phase 1
Covid-19 therapeutics antibody
ATBM-36M Spike/Covid-19
ATBM-14M Spike/Covid-19
Cancer therapeutics antibody
SLAM7-53 SLAM7/MM
Neobody-101 Undisclosed
Cancer CAR-T therapy
ATBM-CarT1 Undisclosed
zh_TWChinese